Publications by authors named "Barbara Zaggia"

Claim this Profile
E
Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma.
Giuseppe Reimondo, Soraya Puglisi, Barbara Zaggia, Vittoria Basile, Laura Saba

Eur J Endocrinol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer.
Elisa Roca, Alfredo Berruti, Silviu Sbiera, Ida Rapa, Ester Oneda, Barbara Zaggia

Endocr Relat Cancer· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the prognostic role of the "Helsinki Score" in 225 cases of adrenocortical carcinoma.
Eleonora Duregon, Rocco Cappellesso, Valeria Maffeis, Barbara Zaggia, Laura Ventura

Hum Pathol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Outcomes of Adjuvant Mitotane Therapy in Patients With Radically Resected Adrenocortical Carcinoma.
Alfredo Berruti, Salvatore Grisanti, Alina Pulzer, Mélanie Claps, Fulvia Daffara, Barbara Zaggia

J Clin Endocrinol Metab· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pitfalls in the diagnosis of adrenocortical tumors: a lesson from 300 consultation cases.
Eleonora Duregon, Marco Volante, Enrico Bollito, Margherita Goia, Consuelo Buttigliero, Barbara Zaggia

Hum Pathol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Midnight Salivary Cortisol as a Predictor Factor for Common Carotid Arteries Intima Media Thickness in Patients with Clinically Inapparent Adrenal Adenomas.
Giuseppe Reimondo, Barbara Allasino, Marcella Coletta, Anna Pia, Giulia Peraga, Barbara Zaggia

Int J Endocrinol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical treatment using mitotane for adrenocortical carcinoma.
Massimo Terzolo, Barbara Zaggia, Barbara Allasino, Silvia De Francia

Curr Opin Endocrinol Diabetes Obes· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Growth hormone values after an oral glucose load do not add clinically useful information in patients with acromegaly on long-term somatostatin receptor ligand treatment.
Giuseppe Reimondo, Marta Bondanelli, Maria Rosaria Ambrosio, Franco Grimaldi, Barbara Zaggia

Endocrine· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane.
Antonio D'Avolio, Silvia De Francia, Vittoria Basile, Jessica Cusato, Francesca De Martino, Barbara Zaggia

Pharmacogenet Genomics· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study.
Paola Sperone, Anna Ferrero, Fulvia Daffara, Adriano Priola, Barbara Zaggia

Endocr Relat Cancer· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective evaluation of the outcome of open versus laparoscopic adrenalectomy for stage I and II adrenocortical cancer.
Francesco Porpiglia, Cristian Fiori, Fulvia Daffara, Barbara Zaggia, Enrico Bollito

Eur Urol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly.
Fulvia Daffara, Silvia De Francia, Giuseppe Reimondo, Barbara Zaggia, Emiliano Aroasio

Endocr Relat Cancer· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The combined low-dose dexamethasone suppression corticotropin-releasing hormone test as a tool to rule out Cushing's syndrome.
Giuseppe Reimondo, Silvia Bovio, Barbara Allasino, Silvia De Francia, Barbara Zaggia

Eur J Endocrinol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis